Show simple item record

dc.creatorTanne, Janice Hopkinsen
dc.date.accessioned2016-01-09T00:33:03Zen
dc.date.available2016-01-09T00:33:03Zen
dc.date.created2011-11-28en
dc.date.issued2011-11-28en
dc.identifierdoi:10.1136/bmj.d7702en
dc.identifier.bibliographicCitationBMJ (Clinical research ed.) 2011 November 28; 343: d7702en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Merck+pays+$1bn+penalty+in+relation+to+promotion+of+rofecoxib.&title=BMJ+&volume=&issue=&date=2011-11&au=Tanne,+Janice+Hopkinsen
dc.identifier.urihttp://dx.doi.org/10.1136/bmj.d7702en
dc.identifier.urihttp://hdl.handle.net/10822/1015235en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:341140en
dc.subject.classificationProfessional Misconducten
dc.subject.classificationDrugs and Drug Industryen
dc.titleMerck Pays $1bn Penalty in Relation to Promotion of Rofecoxiben
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885